ARCHIVES

Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific

This article is from The Cancer Letter archive.

Vol. 37 No. 32 | August 12, 2011

Download PDF Visit The Full Archive

Related Articles

Shuttle Vector Technology Concept Approved

February 28, 1986

Medicare Will Cover Patient Care Costs For All Phases Of Cancer Treatment Trials.

September 1, 2000

New NCI Division Wins Approval To Fund Grants In Basic Biobehavioral Research

April 17, 1998

Abortion, Miscarriage Don’t Increase Breast Cancer Risk, NCI Workshop Finds

March 7, 2003

Young Elected ACS President, Von eschenback Pres.-Elect.

November 9, 2001

Clinical Trials Approved By NCI CTEP Last Month

March 25, 2011